For Q4 FY 2014-15, revenues were at Rs 1,154 crores down by six per cent from Rs 1,225 crores
Ahmedabad-based Torrent Pharmaceuticals released its financial results for the quarter and year ended March 31, 2015. For Q4 FY 2014-15, revenues were at Rs 1,154 crores down by six per cent from Rs 1,225 crores during the same period last year. Earnings before interest, taxes, depreciation, and amortisation (EBITDA) for Q4 FY 2014-15 was at Rs 259 crores down by 26 per cent from Rs 350 crores during the same period last year.
PAT for Q4 FY 2014-15 was at Rs 130 crores down by 47 per cent from Rs 244 crores during the same period last year. Adjusting for one-offs during the quarter, revenue growth is 10 per cent, EBITDA growth is 34 per cent and PAT growth is 60 per cent.
For FY 2014-15, revenues were at Rs 4,653 crores, up by 11 per cent from Rs 4,184 crores in previous year. EBITDA for FY 2014-15 was at Rs 1,280 crores up by 36 per cent from Rs 942 crores in the previous year. PAT for FY 2014-15 was at Rs 751 crores up by 13 per cent compared to Rs 664 crores during the previous year. Adjusting for one-offs during the year, revenues will be up by 13 per cent, EBITDA will be up by 61 per cent and PAT will be up by 71 per cent.
The management and board (subject to shareholders approval) have recommended dividend of Rs 6.25 per share.
- Advertisement -
Comments are closed.